Ani Pharmaceuticals (ANIP) Retained Earnings (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Retained Earnings of $6.4 million for Q1 2026, down 98.93% sequentially from $596.0 million in Q4 2025, and up 77.09% YoY from $3.6 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Retained Earnings (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Retained Earnings for 17 years, with the latest figure at $6.4 million in Q1 2026.
- Quarterly Retained Earnings rose 77.09% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 77.09% YoY) and the FY2025 annual result came in at $596.0 million, up 11053.37% from the prior year.
- Retained Earnings fell to $6.4 million in Q1 2026 per ANIP's latest filing, from $596.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at $596.0 million in Q4 2025 and troughed at -$97.3 million in Q4 2022.
- A 5-year average of $98.2 million and a median of $6.4 million in 2026 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slumped 1439.3% in 2022, then soared 11053.37% in 2025.
- Over 5 years, Retained Earnings stood at -$97.3 million in 2022, then surged by 109.1% to $8.9 million in 2023, then sank by 39.66% to $5.3 million in 2024, then jumped by 11053.37% to $596.0 million in 2025, then sank by 98.93% to $6.4 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $6.4 million, $596.0 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 620.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 620.25 Mn |
| Mar 31, 2026 | 6.39 Mn |
| Dec 31, 2025 | 596.04 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 541.90 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 5.34 Mn |
| Sep 30, 2024 | -89.60 Mn |
| Jun 30, 2024 | 8.33 Mn |
| Mar 31, 2024 | 9.41 Mn |
| Dec 31, 2023 | 8.86 Mn |
| Sep 30, 2023 | 14.08 Mn |
| Jun 30, 2023 | 495.49 Mn |
| Mar 31, 2023 | 408.40 Mn |
| Dec 31, 2022 | -97.29 Mn |
| Sep 30, 2022 | -92.60 Mn |
| Jun 30, 2022 | -83.63 Mn |
| Mar 31, 2022 | -68.30 Mn |
| Dec 31, 2021 | 387.84 Mn |
| Sep 30, 2021 | -23.44 Mn |